Our Product
Symbio develops and manufactures a diverse portfolio of Active Pharmaceutical Ingredients (APIs) and pharmaceutical enzymes, spanning multiple therapeutic areas and complex chemistries. Each product is built on our research-led development engine, emphasizing process optimization, green chemistry, and scalable innovation across our facilities in India.
Our portfolio continues to evolve through strategic collaborations and CDMO partnerships, where we co-develop advanced intermediates, APIs, and enzymes for both regulated and emerging markets. To explore collaboration opportunities or request our detailed product list, please contact symbio@symbiogenerics.com
Symbio Vizag
Ursodeoxycholic Acid (CEP)(US DMF)
Minoxidil (US DMF)
Empagliflozin (US DMF)
Oxcarbazepine (US DMF)
Tauro-Ursodeoxycholic Acid
Nor-Ursodeoxycholic Acid
Dapagliflozin
Valganciclovir
Verapamil
Edoxaban
Finerenone
Resmetirom
Tegoprazan
VPL Chemical
Minoxidil (CEP)
Eslicarbazepine
Fexofenadine
Ambroxol
Pregabalin
Symbio Tumakuru
Pancreatin IP/USP/Ph Eur
Trypsin Chymotrypsin
Trypsin BP
Rutoside Trihydrate BP
Pepsin IP
Mycophenolate Mofetil
Mycophenolate Sodium
Pellets & Granules
Pancreatin Pellets
Pancreatin Granules
Alpha Lipoic Acid Granules 80%
Alpha Lipoic Acid Pellets 60%
Orlistat Pellets
Trypsin Chymotrypsin E.C. Granules
Serratiopeptidase E.C. Granules
Trypsin - Bromelain - Rutoside
Dabigatran Pellets
CMO Facility
CoEnzyme Q10
Chondroitin Sulphate
Levocarnitine
L-Carnitine L-Tartrate
Glucosamine
India Market Products
Montelukast
Tranexamic Acid IP
Orlistat
Enoxaparin Sodium IP/USP
Heparin Sodium IP
Acarbose IP
Sitagliptin IP
Mifepristone IP
Product Pipeline
Semaglutide
Tafamidis
Apixaban
Rivaroxaban
Galantamine
Bempedoic Acid
Bilastine
Valacyclovir